280 related articles for article (PubMed ID: 32407969)
1. Associations Between Nonalcoholic Fatty Liver Disease and Cancers in a Large Cohort in China.
Wang Z; Zhao X; Chen S; Wang Y; Cao L; Liao W; Sun Y; Wang X; Zheng Y; Wu S; Wang L
Clin Gastroenterol Hepatol; 2021 Apr; 19(4):788-796.e4. PubMed ID: 32407969
[TBL] [Abstract][Full Text] [Related]
2. The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.
Lee TY; Wu JC; Yu SH; Lin JT; Wu MS; Wu CY
Int J Cancer; 2017 Oct; 141(7):1307-1314. PubMed ID: 28509327
[TBL] [Abstract][Full Text] [Related]
3. Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China.
Yuan X; Wang X; Wu S; Chen S; Wang Y; Wang J; Lu Y; Sun Y; Fu Q; Wang L
Hepatobiliary Surg Nutr; 2023 Oct; 12(5):671-681. PubMed ID: 37886198
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Fatty Liver Disease and Risk of Diabetes: A Prospective Study in China.
Shen X; Cai J; Gao J; Vaidya A; Liu X; Li W; Chen S; Zhou Y; Li Y; Zhang Y; Zhao J; Hu FB; Wu S; Gao X
Endocr Pract; 2018 Sep; 24(9):823-832. PubMed ID: 29975579
[TBL] [Abstract][Full Text] [Related]
6. Association of nonalcoholic fatty liver disease and liver cancer.
Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
[TBL] [Abstract][Full Text] [Related]
7. Association between nonalcoholic fatty liver disease and extrahepatic cancers: a systematic review and meta-analysis.
Liu SS; Ma XF; Zhao J; Du SX; Zhang J; Dong MZ; Xin YN
Lipids Health Dis; 2020 May; 19(1):118. PubMed ID: 32475354
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
Hwang YC; Ahn HY; Park SW; Park CY
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
[TBL] [Abstract][Full Text] [Related]
9. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
[TBL] [Abstract][Full Text] [Related]
10. Risk of hepatic and extrahepatic cancer in NAFLD: A population-based cohort study.
Björkström K; Widman L; Hagström H
Liver Int; 2022 Apr; 42(4):820-828. PubMed ID: 35152526
[TBL] [Abstract][Full Text] [Related]
11. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
[TBL] [Abstract][Full Text] [Related]
12. Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B.
Cho H; Chang Y; Lee JH; Cho YY; Nam JY; Lee YB; Lee DH; Cho EJ; Yu SJ; Kim YJ; Lee JM; Yoon JH
J Clin Gastroenterol; 2020 Aug; 54(7):633-641. PubMed ID: 31033805
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with the development of extrahepatic malignancy in patients with nonalcoholic fatty liver disease: a single-center longitudinal study.
Gumussoy M; Koc O; Karatas G; Ozercan M; Ellik Z; Duman S; Kiremitci S; Gokcan H; Elhan AH; Savas B; Idilman R
Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1172-1177. PubMed ID: 36170687
[TBL] [Abstract][Full Text] [Related]
14. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
Perumpail RB; Wong RJ; Ahmed A; Harrison SA
Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea.
Kwon H; Han KD; Moon SJ; Park SE; Rhee EJ; Lee WY
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1095-e1104. PubMed ID: 37921093
[TBL] [Abstract][Full Text] [Related]
18. Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population.
Meng G; Zhang B; Yu F; Li C; Zhang Q; Liu L; Wu H; Xia Y; Bao X; Shi H; Su Q; Gu Y; Fang L; Yang H; Yu B; Sun S; Wang X; Zhou M; Jia Q; Jiao H; Wang B; Guo Q; Carvalhoa LA; Sun Z; Song K; Yu M; Niu K
Eur J Nutr; 2018 Sep; 57(6):2113-2121. PubMed ID: 28702720
[TBL] [Abstract][Full Text] [Related]
19. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
20. NAFLD and MAFLD as emerging causes of HCC: A populational study.
Myers S; Neyroud-Caspar I; Spahr L; Gkouvatsos K; Fournier E; Giostra E; Magini G; Frossard JL; Bascaron ME; Vernaz N; Zampaglione L; Negro F; Goossens N
JHEP Rep; 2021 Apr; 3(2):100231. PubMed ID: 33748726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
